ERBC provides a full range of GLP-compliant toxicology studies to evaluate the safety of pharmaceuticals, chemicals, agrochemicals, cosmetics, and medical devices.
Our studies assess potential systemic, repeated-dose, and organ-specific toxic effects, delivering reliable data for regulatory submissions and risk assessment.
With scientific expertise and regulatory insight, we customize study protocols to meet specific development needs, integrating alternative models and advanced analytical approaches for enhanced evaluation.
